This inventor holds 21 USPTO granted patents and 6 published patent applications and 10 EPO patents, primarily in Cancer Therapeutics. Top assignees: Deciphera Pharmaceuticals, LLC, Biocryst Pharmaceuticals, Inc., Eli Lilly and Company. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Arlington, MA (US) (2015 - 2016)
- Lawrence, KS (US) (2015 - 2023)
- Waltham, MA (US) (2022 - 2024)
Company Filing History:
13 out of 99 
8 out of 92 
1 out of 4,517 
Years Active: 2015-2025
Areas of Expertise:
Title: Lakshminarayana Vogeti: Pioneering Innovations in Biopharmaceuticals
Introduction:
Lakshminarayana Vogeti, a prominent inventor based in Lawrence, KS (US), is renowned for his innovative spirit and dedication to advancing technology in the realm of biopharmaceuticals. With a commendable portfolio of 16 patents, Vogeti is setting new standards in shaping the landscape of innovation.
Latest Patents:
Vogeti's latest patents include groundbreaking inventions in the field of biopharmaceuticals. One of his remarkable creations is the development of Human plasma kallikrein inhibitors, which are compounds designed to inhibit plasma kallikrein and hold promising implications for treating diseases characterized by unwanted plasma kallikrein activity. Additionally, Vogeti has also introduced Prodrugs of kallikrein inhibitors, aimed at combatting acquired or hereditary angioedema and other conditions associated with aberrant kallikrein activity.
Career Highlights:
Having made significant contributions to the field, Vogeti has worked with reputable companies such as Deciphera Pharmaceuticals, LLC, and Biocryst Pharmaceuticals, Inc. His innovative work within these organizations has paved the way for groundbreaking solutions in biopharmaceutical research and development.
Collaborations:
Throughout his career, Vogeti has collaborated with esteemed professionals in the industry, including his coworkers Daniel L. Flynn and Timothy Malcolm Caldwell. These collaborations have not only enriched his inventive journey but have also fostered a culture of shared knowledge and expertise within the field of biopharmaceuticals.
Conclusion:
In conclusion, Lakshminarayana Vogeti's relentless pursuit of innovation and his commitment to pushing the boundaries of technology have positioned him as a standout figure in the world of inventors. With a promising future ahead, Vogeti continues to shape the landscape of biopharmaceutical innovation, leaving a lasting impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile